NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amygdala Neurosciences

Amygdala Neurosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://amygns.com/

Last Round

VC Round

May 14, 2024

Total Funding Raised

$15.75M

Company Overview

Amygdala Neurosciences is a biopharmaceutical company that discovers and develops novel pharmacotherapies to treat substance use disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

SUDsubstance use disorderALDH2 inhibitoraddiction treatmentaddiction medicinepharmacotherapydrug developmentbiopharmaceuticalclinical trialscravings suppressionsmall moleculerehab techbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amygdala Neurosciences Comps

Public and private peers based on sector, stage, and business model.

Amygdala Neurosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amygdala Neurosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 14, 2024
GrantAug 1, 2023
VC RoundNov 18, 2019
GrantOct 21, 2019
GrantSep 19, 2018

Key People

Founding team and executive leadership

Adrienne MacMillan

Founder, CFO and Board Member, CFO

Founding Team

Brent Blackburn

Chief Executive Officer and Founder

Founding Team

Amygdala Neurosciences Investors

Notable investors and investment history

Amygdala Neurosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amygdala Neurosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amygdala Neurosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2015
Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.